Lv1
20 积分 2025-10-11 加入
Strategic innovations: Tackling challenges of immunotherapy in acute myeloid leukemia
20天前
已完结
EZH2 Inhibition and Myeloid Risk: A Feature of On-Target Biology
20天前
已完结
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors
1个月前
已完结
An updated patent review of EZH2 inhibitors (2024–present)
1个月前
已完结
DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy
6个月前
已完结
An ATPase-Deficient Variant of the SNF2 Family Member HELLS Shows Altered Dynamics at Pericentromeric Heterochromatin
6个月前
已完结
KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition
6个月前
已完结
EZH2 inhibition sensitizes MYC-high medulloblastoma cancers to PARP inhibition by regulating NUPR1-mediated DNA repair
7个月前
已完结
Discussion on the Structural Modification and Anti-tumor Activity ofFlavonoids
7个月前
已完结
The global epidemiology of acute myeloid leukaemia
7个月前
已完结
皖公网安备34019202002308
